Publicacións (22) Publicacións de María Teresa Diz-Lois Palomares

2024

  1. Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 10, pp. 1325-1338

2023

  1. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

  2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  3. Pharmacokinetic and clinical monitoring through posologic changes in adalimumab intensification regimen from 40 mg every week to 80 mg every other week

    Revista Espanola de Enfermedades Digestivas, Vol. 114, Núm. 12, pp. 708-712

  4. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Effectiveness of ustekinumab in fistulising perianal Crohn′s disease refractory or intolerant to anti-TNF

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S419-S420

  2. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  3. Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study

    Therapeutic Advances in Gastroenterology, Vol. 14

  4. Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study

    Journal of Crohn's and Colitis, Vol. 15, Núm. Supplement_1, pp. S018-S020

2020

  1. Crohn's disease in patients treated with etanercept

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 112, Núm. 1, pp. 80-81

2018

  1. Genital granulomatosis in male and female patients with Crohn's disease: Clinical presentation and treatment outcomes

    Journal of Crohn's and Colitis, Vol. 12, Núm. 2, pp. 197-203

  2. Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study

    American Journal of Gastroenterology, Vol. 113, Núm. 3, pp. 396-403

2017

  1. Nuevas moléculas: un abordaje de práctica clínica. Ustekinumab

    Inflamatoria: Revista oficial del grupo EIGA, Núm. 11, pp. 8-14

2016

  1. Pseudotumor inflamatorio hepático linfoplasmocítico

    Anales del sistema sanitario de Navarra, Vol. 39, Núm. 2, pp. 305-308

2010

  1. Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation

    European Journal of Endocrinology, Vol. 163, Núm. 4, pp. 609-616

2009

  1. Fasting and postprandial plasma ghrelin levels are decreased in patients with liver failure previous to liver transplantation

    Endocrine, Vol. 35, Núm. 3, pp. 467-476

2007

  1. Acetic acid allows effective selection of areas for obtaining biopsy samples in Barrett's esophagus

    European Journal of Gastroenterology and Hepatology, Vol. 19, Núm. 3, pp. 187-193

2005

  1. Masa submucosa rectal y meningitis aguda: Presentación de un meningocele sacro anterior

    Revista Espanola de Enfermedades Digestivas

2004

  1. Jejunal leiomyosarcoma, a rare cause of obscure gastrointestinal bleeding diagnosed by wireless capsule endoscopy.

    Surgical endoscopy, Vol. 18, Núm. 3, pp. 554-556